toggle navigation
HOME
ABOUT
Overview
History
Our Leadership
Our Advisors
Our Values
TECHNOLOGY
ATRIVIEW® CNS Drug Screening Platform
SHINE MOUSE® and NuvoMab™ Platform
Publications
PIPELINE
NEWS
News Release
Company Notice
CONTACT
LANGUAGE
KOREAN
ENGLISH
toggle navigation
HOME
ABOUT
Overview
History
Our Leadership
Our Advisors
Our Values
TECHNOLOGY
ATRIVIEW® CNS Drug Screening Platform
SHINE MOUSE® and NuvoMab™ Platform
Publications
PIPELINE
NEWS
News Release
Company Notice
CONTACT
LANGUAGE
KOREAN
ENGLISH
EN
|
KR
News
Title
GENUV, Receives Approval for ALS Phase 1·2a Clinical Studies on New Drug Candidate
2019-09-19
Link :
https://news.mt.co.kr/mtview.php?no=2019091911285275387
Prev
GENUV CEO Sung-Ho Han, "To make real progress in the treatment of ALS and give hope to the patients"
Next
GENUV, Receives Approval for ALS Phase 1·2a Clinical Studies on New Drug "SNR1611"
list
